OBJECTIVE: To determine in a group of pregnant women if vitamin D status, based on serum 25-hydroxyvitamin D (25OHD) concentration, was associated with a subsequent risk of pre-eclampsia or adverse pregnancy outcomes. DESIGN: Prospective cohort study. SETTING: Vancouver, British Columbia, Canada (49°N). POPULATION: Women attending a specialist antenatal clinic because of clinical or biochemical risk factors for pre-eclampsia (n = 221). METHODS: Serum 25OHD concentration measured between 10 and 20 weeks of gestation. MAIN OUTCOME MEASURES: Pre-eclampsia and composite adverse pregnancy outcomes. RESULTS: Of the women, 78% were vitamin D insufficient (25OHD <75 nmol/l) and 53% were vitamin D deficient (25OHD <50 nmol/l). There was no difference in the rates of pre-eclampsia, gestational hypertension, preterm birth or composite adverse pregnancy outcomes by 25OHD concentration. CONCLUSIONS: Vitamin D deficiency and insufficiency were common in a group of women at high risk of pre-eclampsia; however, it was not associated with subsequent risk of an adverse pregnancy outcome.
OBJECTIVE: To determine in a group of pregnant women if vitamin D status, based on serum 25-hydroxyvitamin D (25OHD) concentration, was associated with a subsequent risk of pre-eclampsia or adverse pregnancy outcomes. DESIGN: Prospective cohort study. SETTING: Vancouver, British Columbia, Canada (49°N). POPULATION: Women attending a specialist antenatal clinic because of clinical or biochemical risk factors for pre-eclampsia (n = 221). METHODS: Serum 25OHD concentration measured between 10 and 20 weeks of gestation. MAIN OUTCOME MEASURES: Pre-eclampsia and composite adverse pregnancy outcomes. RESULTS: Of the women, 78% were vitamin D insufficient (25OHD <75 nmol/l) and 53% were vitamin D deficient (25OHD <50 nmol/l). There was no difference in the rates of pre-eclampsia, gestational hypertension, preterm birth or composite adverse pregnancy outcomes by 25OHD concentration. CONCLUSIONS:Vitamin Ddeficiency and insufficiency were common in a group of women at high risk of pre-eclampsia; however, it was not associated with subsequent risk of an adverse pregnancy outcome.
Authors: Candace Y Parker-Autry; Alayne D Markland; Alicia C Ballard; Deidra Downs-Gunn; Holly E Richter Journal: Int Urogynecol J Date: 2012-03-08 Impact factor: 2.894
Authors: Luisa A Wetta; Joseph R Biggio; Suzanne Cliver; Adi Abramovici; Stephen Barnes; Alan T N Tita Journal: Am J Perinatol Date: 2013-09-10 Impact factor: 1.862
Authors: Clifford J Rosen; John S Adams; Daniel D Bikle; Dennis M Black; Marie B Demay; JoAnn E Manson; M Hassan Murad; Christopher S Kovacs Journal: Endocr Rev Date: 2012-05-17 Impact factor: 19.871
Authors: Lisa M Bodnar; Mark A Klebanoff; Alison D Gernand; Robert W Platt; W Tony Parks; Janet M Catov; Hyagriv N Simhan Journal: Am J Epidemiol Date: 2013-10-11 Impact factor: 4.897
Authors: Lisa M Bodnar; Hyagriv N Simhan; Janet M Catov; James M Roberts; Robert W Platt; Jill C Diesel; Mark A Klebanoff Journal: Epidemiology Date: 2014-03 Impact factor: 4.822
Authors: Candace Y Parker-Autry; Jonathan L Gleason; Russell L Griffin; Alayne D Markland; Holly E Richter Journal: Int Urogynecol J Date: 2014-05-08 Impact factor: 2.894
Authors: Yan Tian; Claudia Holzman; Anna M Siega-Riz; Michelle A Williams; Nancy Dole; Daniel A Enquobahrie; Cynthia D Ferre Journal: Paediatr Perinat Epidemiol Date: 2015-11-17 Impact factor: 3.980